Few, If Any, Doses of Spikevax or Comirnaty Available in United States, Despite FDA Approvals

Moderna's COVID-19 vaccine is prepared in Los Angeles, Calif., on Jan. 7, 2022. Frederic J. Brown/AFP via Getty Images

U.S. drug regulators have fully approved the COVID-19 vaccines made by Pfizer and Moderna more than a year after granting them emergency use authorization (EUA), but the approved versions of the vaccines don’t appear to be available yet in the United States.

The Food and Drug Administration (FDA) approved Moderna’s jab on Jan. 31, about five months after it approved Pfizer’s shot.